Society for Advanced Bronchoscopy Webinar to Highlight bioAffinity Technologies’ CyPath Test

A multidisciplinary panel of physicians is preparing to discuss a new medical testing approach. The focus will be on the real-world benefits of bioAffinity Technologies’ noninvasive CyPath test. This specific test is designed for the detection of lung cancer. The discussion will take place during an upcoming webinar hosted by the Society for Advanced Bronchoscopy. Business Wire reported that the event aims to educate medical professionals on clinical applications. The panel will share insights derived from actual usage of the CyPath lung cancer test. Highlighting noninvasive methods is a key goal of the scheduled educational session. The webinar represents an important step in raising awareness about advanced diagnostic options.